Alexion to acquire Boston startup Syntimmune for up to $1.2B

It's the first local company that Alexion has acquired since moving its headquarters from New Haven, Connecticut, to Boston's Seaport District.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.